Sartobind APPeals to the Mobile Market
According to the motto “Sartobind goes mobile” Sartorius Stedim Biotech introduces its first smartphone application (App) for the Sartobind membrane adsorber portfolio. The Sartobind App provides mobile users with useful selection and training tools to complement the product portfolio, and provides links to all the literature available in the digital library.
The product finder feature enables the beginners and experts to select the appropriate membranes required for capture chromatography that is utilized in binding viruses or large proteins versus flow-through polishing processes, which is used to remove DNA, host cell proteins and other charged contaminants from a target molecule. Those new to chromatography will benefit from using the Ion Exchange Calculator to better understand the interplay between pH and the isoelectric point of the protein of interest. More experienced users will appreciate the flexible search function for downloading application notes and other literature by search parameters related to target molecule, membrane type, device format and scale. Other valuable features for all users are a flow rate calculator, an isoelectric point list for proteins and viruses, a comprehensive chromatography glossary, and a FAQ document.
The English-language Web App requires direct access to the Internet. It has been optimized for Apple iPhones, but will run on many android smartphones. The following link can be used to download this App on your smartphone: https://app.sartorius.com/
Related News
-
News Novartis signs US$3.2 bn subcutaneous delivery deal with Alteogen
Swiss pharma giant secures access to Korean biotech's ALT-B4 hyaluronidase platform in milestone-heavy agreement, marking Alteogen's fourth major licensing deal of 2026 as competition intensifies in the subcutaneous drug delivery space.
-
News Women in Pharma: The philosophy of pharmaceutical leadership
In this latest instalment of our Women in Pharma series, we sit down with Clarissa Sowemimo-Coker, Chief Strategy Officer at Ambrose Healthcare and CPHI Middle East Advisory Board Member.
-
News The PSCI Supplier Partnership - Collaboration for Responsible Supply Chains
About the Pharmaceutical Supply Chain Initiative The Pharmaceutical Supply Chain Initiative (PSCI) is the leading, member-led association for pharmaceutical companies working collaboratively to build responsible supply chains. Founded in 2006 and es... -
News AstraZeneca shares plunge 8.9% after reports of BMS talks
Britain's largest drugmaker lost more than GBP£17 billion in market value following reports of preliminary merger discussions with Bristol Myers Squibb that could create a pharmaceutical giant worth nearly US$400 billion, though investors rem... -
News GSK announces £400 million investment in new Cambridge R&D centre
Pharmaceutical giant to establish flagship research facility on Cambridge Biomedical Campus as part of strategic pipeline acceleration
-
News The CPHI Sustainability Summit - Where Conversation Becomes Collaboration
The Report Was Never the Destination - “The future of pharmaceutical sustainability won’t be shaped by individual organisations working in isolation. It will be shaped by partnerships, shared expertise and the willingness to work diffe... -
News Trump's generic drug tariffs set to reshape global pharmaceutical supply chains
The US president has announced plans to impose tariffs of up to 200% on imported generic medicines from August 2028, giving manufacturers a two-year window to establish domestic production facilities. The move threatens to upend a global supply chain t... -
News Building Safer, More Responsible Pharmaceutical Supply Chains: PSCI Global Audit Insights
The Pharmaceutical Supply Chain Initiative (PSCI) has released its seventh annual Audit Findings Analysis Report, offering unprecedented insights into supplier practices across the global pharmaceutical and healthcare industry.With a record-breaking 24...